Related Experiment Video

Updated: May 12, 2026

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
08:42

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model

Published on: July 3, 2020

Cysteine proteinase inhibitors regulate human and mouse osteoclastogenesis by interfering with RANK signaling

Fredrik Strålberg1, Petra Henning, Inger Gjertsson

  • 1Department of Molecular Periodontology, Umeå University, SE-901 87 Umeå, Sweden.

FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|April 11, 2013
PubMed

Insights

Cystatin C, a cysteine proteinase inhibitor, effectively blocks osteoclast formation and differentiation. This inhibition occurs by interfering with intracellular signaling pathways downstream of RANK, impacting key gene expression and cellular processes.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Immunology

Background:

  • Osteoclasts are crucial for bone remodeling.
  • RANKL signaling is essential for osteoclastogenesis.
  • Cysteine proteinase inhibitors are being investigated for their biological effects.

Purpose of the Study:

  • To investigate the effect of cystatin C on osteoclast formation and differentiation.
  • To elucidate the underlying molecular mechanisms of cystatin C's action.
  • To compare the efficacy of different cysteine proteinase inhibitors.

Main Methods:

  • Mouse bone marrow macrophage cultures stimulated with RANKL.
  • Osteoclast cultures on bone to assess resorption.
  • Human CD14(+) monocyte differentiation assays.
  • Analysis of gene and protein expression (e.g., c-Fos, Nfatc1).

Main Results:

  • Cystatin C significantly inhibited RANKL-induced osteoclast formation and bone resorption.
  • Inhibition was concentration-dependent and associated with decreased expression of key osteoclastogenic genes.
  • Cystatin C interfered with early RANKL signaling, including c-Fos expression and nuclear translocation.
  • Other cysteine proteinase inhibitors (cystatin D, Z-RLVG-CHN2, E-64) also showed inhibitory effects.

Conclusions:

  • Cystatin C is a potent inhibitor of osteoclast differentiation and formation.
  • Its mechanism involves intracellular interference with signaling pathways downstream of RANK.
  • Cystatin C represents a potential therapeutic target for bone-related disorders involving excessive osteoclast activity.
Keywords:
Nfatc1c-Foscystatin Costeoclasts

More Related Videos

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation09:37

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation

Published on: March 15, 2018

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult body.
A...
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...